Signet Financial Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-8,163
| Closed | -$3.8M | – | 280 |
|
|
2024
Q3 | $3.8M | Buy |
8,163
+51
| +0.6% | +$23.7K | 0.48% | 65 |
|
|
2024
Q2 | $3.8M | Buy |
8,112
+82
| +1% | +$38.4K | 0.51% | 61 |
|
|
2024
Q1 | $3.36M | Buy |
8,030
+122
| +2% | +$51K | 0.46% | 70 |
|
|
2023
Q4 | $3.22M | Sell |
7,908
-26
| -0.3% | -$10.6K | 0.48% | 68 |
|
|
2023
Q3 | $2.76M | Sell |
7,934
-96
| -1% | -$33.4K | 0.46% | 74 |
|
|
2023
Q2 | $2.83M | Buy |
8,030
+37
| +0.5% | +$13K | 0.45% | 73 |
|
|
2023
Q1 | $2.52M | Buy |
7,993
+68
| +0.9% | +$21.4K | 0.42% | 78 |
|
|
2022
Q4 | $2.29M | Buy |
7,925
+106
| +1% | +$30.6K | 0.41% | 83 |
|
|
2022
Q3 | $2.26M | Buy |
7,819
+184
| +2% | +$53.3K | 0.44% | 68 |
|
|
2022
Q2 | $2.15M | Buy |
+7,635
| New | +$2.15M | 0.41% | 70 |
|
|
2022
Q1 | – | Sell |
-201
| Closed | -$44K | – | 1308 |
|
|
2021
Q4 | $44K | Buy |
+201
| New | +$44K | 0.01% | 529 |
|
|
2018
Q4 | – | Sell |
-903
| Closed | -$174K | – | 801 |
|
|
2018
Q3 | $174K | Buy |
903
+59
| +7% | +$11.4K | 0.03% | 237 |
|
|
2018
Q2 | $144K | Hold |
844
| – | – | 0.03% | 261 |
|
|
2018
Q1 | $138K | Buy |
+844
| New | +$138K | 0.02% | 244 |
|